Repligen (RGEN) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $126.37 --0%
EPS Growth %: +21.6%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +21.6%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $25.6 million versus the consensus estimate of $24.05 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Q1 EPS miss sends shares down 9% after-hours
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
